Drug profile · INN
buprenorphine hydrochloride
BUPRENORPHINE HYDROCHLORIDE
buprenorphine hydrochloride (BUPRENORPHINE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
Drug details — buprenorphine hydrochloride
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 2
- Programs
- 12
- Data quality
- 0.89
Quick answer
buprenorphine hydrochloride (BUPRENORPHINE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is buprenorphine hydrochloride?
buprenorphine hydrochloride (BUPRENORPHINE HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for buprenorphine hydrochloride?
BUPRENORPHINE HYDROCHLORIDE is a marketed brand name for buprenorphine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of buprenorphine hydrochloride?
buprenorphine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.